Transcriptional repression of the TSH-specific b subunit (TSHb) gene has been regarded to be specific to thyroid hormone (tri-iodothyronine, T 3 ) and its receptors (TRs) in physiological conditions. However, TSHb mRNA levels in the pituitary were reported to decrease in the administration of pharmacologic doses of estrogen (17-b-estradiol, E 2 ) and increase in E 2 receptor (ER)-a null mice. Here, we investigated the molecular mechanism of inhibition of the TSHb gene expression by E 2 -bound E 2 -estrogen receptor 1 (E 2 -ERa). In kidney-derived CV1 cells, transcriptional activity of the TSHb promoter was stimulated by GATA2 and suppressed by THRBs and ERa in a ligand-dependent fashion. Overexpression of PIT1 diminished the E 2 -ERa-induced inhibition, suggesting that PIT1 may protect GATA2 from E 2 -ERa targeting by forming a stable complex with GATA2. Interacting surfaces between ERa and GATA2 were mapped to the DNA-binding domain (DBD) of ERa and the Zn finger domain of GATA2. E 2 -dependent inhibition requires the ERa amino-terminal domain but not the tertiary structure of the second Zn finger motif in E 2 -ERa-DBD. In the thyrotroph cell line, TaT1, E 2 treatment reduced TSHb mRNA levels measured by the reverse transcription PCR. In the human study, despite similar free thyroxine levels, the serum TSH level was small but significantly higher in post-than premenopausal women who possessed no anti-thyroid antibodies (1 . 90 mU/mlG0 . 13 S.E.M. vs 1 . 47 mU/mlG0 . 12 S.E.M., P!0 . 05). Our findings indicate redundancy between T 3 -TR and E 2 -ERa signaling exists in negative regulation of the TSHb gene. (2008) 199, 113-125 Cga were dramatically elevated. Compared with wild-type mice, the amount of mRNA for Tshb and Cga in Esra null mice increased by 3 . 20-and 4 . 36-fold respectively. Immunostaining using specific antibodies revealed that the number of TSHb-and CGA-positive cells also increased (Scully et al. 1997) . These findings are similar to observations in mice devoid of all known T 3 receptors (TRs; Gothe et al. 1999) . Although these observations suggest that E 2 suppresses TSHb expression via ERa, the molecular mechanism has not been clarified.
Introduction
Thyrotropin (thyroid-stimulating hormone, TSH) is a heterodimer consisting of the TSH-specific b subunit (TSHb) and the chorionic gonadotropin a chain (CGA) that is common to luteinizing hormone (LH), folliclestimulating hormone (FSH), and chorionic gonadotropin. Thyroid hormone (tri-iodothyronine, T 3 )-mediated negative feedback of TSH production in the pituitary is a central mechanism of the pituitary-thyroid axis and is believed to be specific to T 3 at physiological concentrations. However, administration of pharmacologic doses of estrogen (17-bestradiol, E 2 ) was known to augment the effect of thyroid hormone replacement to suppress TSHb and CGA mRNA (Wondisford 1996 and references therein) . Indeed, E 2 inhibits the upregulation of Tshb and Cga mRNA in the pituitary of hypothyroid rats (Franklyn et al. 1987) . Bottner & Wuttke (2005) and Bottner et al. (2006) reported that ovariectomy increased pituitary TSHb mRNA levels and that this elevation was abolished by 17b-E 2 -3-benzoate treatment. Boado et al. (1983) showed that E 2 benzoate induced a marked depression of intrapituitary TSH. Sekulic et al. (1998) demonstrated that E 2 treatment reduced the number of TSHb-positive cells in the rat pituitary.
There are two types of estrogen receptors (ERs), ERa and ERb. In the anterior lobe of the pituitary, ERa is the major receptor (Kuiper et al. 1996 , Pelletier et al. 2000 , Liu & Cui 2005 and is expressed in thyrotrophs as well as gonadotrophs (Stefaneanu et al. 1994 , Gittoes et al. 1997 . Interestingly, Scully et al. (1997) reported that, in the pituitary of ERa-deficient mice, mRNA levels for not only Lhb and Fshb but also Tshb and ER and TR belong to the nuclear hormone receptor superfamily and share a basic structure consisting of a receptor-specific amino-terminal domain (NTD), central DNA-binding domain (DBD), and carboxyl (C)-terminal ligand-binding domain (LBD; Mangelsdorf et al. 1995) . In the promoter region of target genes whose transcription is enhanced by treatment with E 2 or T 3 , ER homodimers and TR heterodimers formed with the retinoid X receptor (RXR) recognize the E 2 -response element (ERE) and the T 3 -response element (TRE) respectively. The tertiary structure of DBDs is maintained by two Zn finger motifs, and the amino acid sequences of the P-and D-boxes of DBD play critical roles in the differential recognition of ERE and TRE (Umesono & Evans 1989 ). E 2 -bound ER (E 2 -ER) and T 3 -bound TR (T 3 -TR) recruit coactivators such as members of the p160 family or CREB-binding protein (CREB)/p300, whose histone acetyl-transferase activities relax the chromatin structure and result in the enhancement of transcription (Perissi & Rosenfeld 2005) . In addition, T 3 -TR (Ito & Roeder 2001 ) and E 2 -ER (Zhang et al. 2005 ) recruit TRAP220, a component of the TRAP/SRB/MEDcontaining cofactor complex of the RNA polymerase II holo-enzyme. In the absence of T 3 , TR recruits co-repressors such as nuclear receptor co-repressor or the silencing mediator of retinoic acid and thyroid hormone receptors (SMRT). These co-repressors associate with histone deacetylases (HDACs), resulting in repression of transcription (Perissi & Rosenfeld 2005) .
Of note, TR and ER have the potential to bind an identical half-site sequence, AGGTCA, although the number of spacing nucleotides between the half-sites and their orientations are different between TRE and ERE (Mangelsdorf et al. 1995) ; ERE can be recognized by the TR monomer, in addition to homodimer and heterodimer with RXR (Klinge et al. 1997) . T 3 -TR can also directly bind to ERE of the promoter for the progesterone receptor gene and stimulate its transcription (Scott et al. 1997 ). On the other hand, when TR and ER coexist, T 3 -TR was reported to inhibit E 2 -ERamediated transactivation of the promoters for the preproenkephalin gene (Zhu et al. 1996 , Vasudevan et al. 2001b ) and the prolactin gene (Pernasetti et al. 1997) , probably via squelching of coactivators common to both receptors. Similar mutual inhibition has been reported between T 3 -TR and other ligand-bound steroid hormone receptors (Zhang et al. 1996) . Thus, the redundancy of DNA recognition and the common utilization of cofactors have been postulated to mediate crosstalk between the E 2 -ER and T 3 -TR signaling pathways (Vasudevan et al. 2001a (Vasudevan et al. , 2002 .
In the mouse TSHb promoter, the DNA sequence between nt K271/K80 (corresponding to the sequence between nt K269/K78 in the human TSHb gene) was reported to be sufficient for maximal promoter activity in thyrotrophs (Wood et al. 1990) . In this promoter region, there are binding sites for two transcription factors, PIT1 and GATA2 (Haugen et al. 1996 , Gordon et al. 1997 , Dasen et al. 1999 , Charles et al. 2006 . Co-existence of PIT1 and GATA2 in thyrotrophs is essential for the expression of the TSHb gene (Gordon et al. 1997 , Dasen et al. 1999 . PIT1 is a pituitary-specific transcription factor expressed in somatotrophs, lactotrophs, and thyrotrophs. GATA2 is a subtype of the GATA family of transcription factors and binds with the GATA-responsive element (GATA-RE) through its Zn finger domain, which has high homology among all GATA family members (Ferreira et al. 2005) . It was recently reported that TRAP220, which is a coactivator for liganded TR and ER, also functions as a coactivator for GATA2 and PIT1 and plays an important role in the transactivation of the TSHb gene (Ito et al. 2000) . In addition, TRAP220 was reported to be a coactivator for GATA1 (Stumpf et al. 2006) , transactivation by which is known to be inhibited by E 2 -ERa (Blobel et al. 1995 , Blobel & Orkin 1996 .
Using non-pituitary CV1 cells, we recently reported that T 3 -TRb2 represses the expression of the TSHb gene driven by GATA2 and PIT1 through interference of GATA2-induced transactivation, and that, contrary to the previous reports, the negative TRE (nTRE; Wondisford et al. 1989 ) and negative regulatory elements (NRE; Sasaki et al. 1999) were not required (Matsushita et al. 2007 ). The reporter assay using CV1 cells provides an ideal experimental platform to investigate the difference between positive and negative regulation by T 3 , since this cell line is one of those most frequently used for the study of positive regulation (Nakano et al. 2004) . We found that THRB-DBD directly interacts with the Zn finger domain of GATA2 (GATA2-Zf) and that T 3 -TR targets TRAP220, which functions as a coactivator for GATA2 in the context of the TSHb promoter (Matsushita et al. 2007 ). Reflecting T 3specificity in vivo, ligand-bound retinoic acid receptor, vitamin D receptor, RXR, or peroxisome proliferator-activated receptor g2 all did not exhibit negative regulation of the TSHb promoter in our experimental system (Nakano et al. 2004) . Unexpectedly, however, E 2 -ERa exhibited significant suppression of the TSHb promoter although the magnitude of suppression (39 . 4%G4 . 5 S.E.M.) was less than that of T 3 -TRb2 (64 . 1%G2 . 6 S.E.M.; Nakano et al. 2004) . Here, we report that, in the negative regulation of the TSHb gene, there is a redundancy between E 2 -ERa-and T 3 -TR-mediated signaling pathways.
Materials and Methods

Plasmid construction
We recently found that not only T 3 -TR (Tillman et al. 1993 , Maia et al. 1996 but also E 2 -ERa have a tendency to suppress firefly luciferase-based reporter gene (data not shown). Thus, we employed the CAT-based reporter system. The TSHb-CAT reporter gene was constructed by fusing the human TSHb promoter (nt. K128/C37) with the CAT reporter gene, whose backbone lacks the pUC-derived AP-1 site (Sasaki et al. 1999 , Nakano et al. 2004 ). TSHb-D4-CAT was reported previously (Matsushita et al. 2007 ). The DNA fragment encompassing the promoter region for TSHb gene K NAGAYAMA and others . E 2 inhibits TSHb gene expression (nt. 615/129) was amplified using PCR from human genomic DNA as template and subcloned into EcoRI site in TSHb-CAT to generate TSHb (615/C37)-CAT. In TSHb-M1-CAT, the putative nTRE/NRE remained intact (data not shown). The expression plasmids for mouse Gata2 (pcDNA3-mGATA2), human PIT1 (pCB6 C -hPit1), wild-type human TRb1 (pCMX-hTRb1), TRb1-deletion mutants (pCI-C1 and C2), wild-type rat Trb2 (pCMX-rTRb2), and human ERa were described previously (Nakano et al. 2004) . The deletion mutants of human ERa (D170 and D247) and mutant ERa such as C205S, C221G, and C240S were generated from wild-type ERa using standard subcloning techniques or a sitedirected mutagenesis kit (Stratagene). The plasmid expressing the recombinant protein of the GATA2 Zn finger domain (GATA2-Zf) combined with glutathione-S-transferase (GST), pGEX-4T-1-GATA2-Zf, was described elsewhere (Matsushita et al. 2007 ). All constructs were confirmed by DNA sequencing.
Cell culture and transient transfection CV1 cells were grown in monolayers and cultured at 37 8C under CO 2 /air (1:19) in Dulbecco's modified Eagle's medium (DMEM) containing 10% dextran-charcoal-stripped fetal bovine serum (10% DCC serum), penicillin G (100 units/ml), and streptomycin (100 mg/ml). TaT1 cells, a mouse thyrotroph cell line (Yusta et al. 1998) , were seeded on Matrigelcoated plates (Becton Dickinson Labware, Bedford, MA, USA). The cells were maintained under the same conditions as CV1 cells. The CV1 cells were trypsinized and plated in 60 mm diameter dishes for 24 h before transient transfection using the calcium phosphate technique (Sasaki et al. 1995) . The cells at a density of 10 6 cells/plate were transfected with 0 . 6 mg of the expression plasmids for Esra or Thrb along with 4 . 0 mg of the Tshb-Cat reporter gene, 1 . 8 mg b-galactosidase expression vector pCH111 (a modified version of pCH110; Pharmacia LKB Biotechnology), 0 . 1 mg human PIT1 expression vector (pCB6 C -hPit1), and 0 . 4 mg mouse Gata2 expression vector (pCDNA3-mGATA2), and the pCMX empty vector as carrier DNA (7 . 2 mg DNA per dish in total).
After the cells were exposed to the calcium phosphate/DNA precipitates for 20 h, the medium was replaced with phenol red-free DMEM containing 5% (v/v) and the cells were allowed to grow for an additional 24 h with or without 1 mM E 2 or T 3 . After incubation for an additional 24 h, the cells were harvested and CAT activity was measured as described previously (Sasaki et al. 1995) . The transfection efficiency was normalized by b-galactosidase assay. For each CAT reporter assay, we performed transfection with CAT reporter gene driven by cytomegalovirus promoter (CMV-CAT; 40 ng/dish), the magnitude of which was adjusted to the value of 100. Immunoblotting with anti-ERa antibody (1:200, cat. sc-8002, Santa Cruz Biotechnology, Santa Cruz, CA, USA) was performed using a standard method described previously (Matsushita et al. 2007 ).
GST pull-down assay
Escherichia coli (DH5a) transformed with pGEX-4T-1-GATA2-Zf were induced with 0 . 1 mM isopropyl-1-thio-bgalactopyranoside for 4 h. The E. coli pellet was sonicated and the fusion proteins were mixed with glutathione-sepharose beads (Amersham Pharmacia Biotech) for purification. Receptor proteins were translated in vitro using rabbit reticulocyte lysate (Promega Corp.) in the presence of 35 S-methionine. Radio-labeled receptors were incubated with GST protein fused to GATA2-Zf (GST-Zf) in the binding buffer (150 mM NaCl, 20 mM Tris-HCl (pH 7 . 5), 0 . 3% Nonidet P-40, 1 mM dithiothreitol, 0 . 5 mM phenylmethylsulfonyl fluoride, 2 mg/ml aprotinin and leupeptin) for 3 h at 4 8C. The precipitants were washed three times with the binding buffer. Bound protein was analyzed by 10% SDS-PAGE and visualized using the FLA-3000 autoradiography system (Fujifilm, Tokyo, Japan).
Gel shift assay
Oligonucleotides for vit-A2 consensus ERE (Scott et al. 1997 ; sense, 5 0 -AATTCGTCCAAAGTCAGGTCACAGTGAC-CTGATCAAAGTT-3 0 ; antisense, 5 0 -AACTTTGATCAG-GTCACTGTGACCTGACTTTGGACGAATT-3 0 ) were labeled with g 32 P-ATP using thyroxine (T 4 )-polynucleotide kinase (Toyobo, Tokyo, Japan). The receptor proteins were translated in vitro using a TNT T7 quick-coupled transcription/translation system (Promega Corp). The radio-labeled probes and in vitro-translated receptors were incubated for 20 min at room temperature in 20 ml binding buffer containing 10 mM HEPES-NaOH (pH 7 . 9), 50 mM KCl, 0 . 1 mM EDTA, 10% glycerol, 0 . 5 mM dithiothreitol, and 0 . 1 mg/ml poly (dI-dC). The DNA-protein complexes were resolved on 5% polyacrylamide gels at 150 V for 1 . 5 h. Gels were dried and visualized using the FLA-3000 autoradiography system.
RNA isolation and real-time reverse transcription-PCR (RT-PCR)
TaT1 cells cultured in 10% DCC serum were incubated in the presence of 1 mM E 2 or T 3 for 48 h. The cells were harvested and total RNAs were purified by the acid guanidium thiocyanate-phenol-chloroform extraction method (Kawai et al. 2004) . For the first-strand cDNA synthesis, 2 mg total RNA were mixed with random hexanucleotides and 200 units Moloney murine leukemia virus reverse transcriptase (Invitrogen Corp). The cDNA for TSHb was amplified with the forward primer (5 0 -GGCAAACTGTTTCTTCCCAA-3 0 ) and the reverse primer (5 0 -TCTGTGGCTTGGTGCAG-TAG-3 0 ). The cDNA for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified with the forward primer (5 0 -TGAACGGGAAGCTCACTGG-3 0 ) and the reverse primer (5 0 -TCCACCACCCTGTTGGCTGTA-3 0 ). PCR amplification was carried out using a DNA thermal cycler (Takara Bio Inc., Shiga, Japan) under the following conditions: denaturation at 95 8C for 1 min, annealing at 62 8C for 1 min, extension at 72 8C for 2 min, and the final extension at 72 8C for 4 min. We determined the cycle number for each primer set so that the specific product was amplified during the exponential phase of the amplification. Based on preliminary studies (data not shown), 27 cycles were employed for the amplification of TSHb and GAPDH cDNA. The PCR products were subjected to electrophoresis on a 1 . 4% agarose gel and stained with ethidium bromide. Using the SYBR Green I kit and Light Cycler (Roche Diagnostics), precipitated DNA was quantified by real-time PCR using the primers mentioned above. The thermal cycling conditions were 10 min at 95 8C, followed by 27 cycles of 10 s at 95 8C for denaturing, 10 s at 62 8C for annealing, and 7 s at 72 8C for extension. PCR signals were analyzed using Light Cycler software Ver. 3.5 (Roche Diagnostics).
Measurement of serum TSH, free T 4 , and E 2 in pre-and postmenopausal women
Among female patients who visited Ito Hospital in May 2004, 134 subjects with simple goiter or thyroid nodule(s) and no thyroid autoantibodies against thyroglobulin, thyroid peroxidase, or TSH receptor were extracted. They were divided into 62 premenopausal women and 72 postmenopausal women. The premenopausal group consisted of women between 30 and 50 years old (37 . 35G5 . 40 years old) and their serum E 2 levels were all higher than 20 pg/ml. The postmenopausal group included women between 50 and 70 (59 . 29G4 . 70) years old with serum E 2 levels lower than 20 pg/ml. TSH and free T 4 were measured with Roche ECLusys kit (Roche) and E 2 with electro chemiluminescence immunoassay (SRL, Tachikawa, Japan).
Statistical analysis
Each experiment was performed in duplicate more than three different times and each result is expressed as the meanGS.E.M. Using StatView 4.0 software (Abacus Concepts Inc., Berkeley, CA, USA), we examined statistical significance in Figs 6 and 7 by Mann-Whitney U test. All other statistical analyses were performed using one-way ANOVA followed by Fisher's protected least significant difference test. P!0 . 05 was considered significant.
Results
TSHb promoter activity is inhibited by not only T 3 -TRb2 but also E 2 -ERa
To explore the molecular mechanism underlying the E 2dependent inhibition of the TSHb gene expression, we carried out a reporter assay using TSHb-CAT ( Fig. 1A) , in which the human TSHb promoter (nt. 128/C37) is fused to the CAT reporter gene. In accordance with previous reports (Gordon et al. 1997 , Dasen et al. 1999 , co-expression of PIT1 and GATA2 transactivated the TSHb promoter in CV1 cells (Fig. 1B, lane 2) . This activity was significantly repressed by not only T 3 -TRb2 but also E 2 -ERa (lanes 2, 4, and 6). When cognate receptors were co-expressed with PIT1 and GATA2, T 3 and E 2 inhibited transcription by 64 . 1%G2 . 6 S.E.M. (lanes 3 and 4) and 39 . 4%G4 . 5 S.E.M. (lanes 5 and 6)
respectively. E 2 -ERa-induced repression depended on the E 2 concentration (Fig. 1C ) and the expression level of ERa (Fig. 1D ). The inhibition of the TSHb promoter by E 2 -ERa was observed in Hela and 293T cells (data not shown). We also examined the effect of E 2 -ERa on the TSHb (K615/C37)-CAT reporter gene, which has longer TSHb promoter encompassing nt. K615/C37, and found again that the transcriptional activity in CV1 cells was stimulated by PIT1 and GATA2, and significantly decreased by 1 mM E 2 (Fig. 1E ).
Overexpression of PIT1 relieves E 2 -dependent inhibition of the TSHb gene and E 2 -ERa targets GATA2-induced transactivation
We tested the effect of PIT1 overexpression on the negative regulation of the TSHb promoter by E 2 -ERa. As shown in Fig. 2A , inhibition by E 2 -ERa was abolished by increased levels of PIT1, suggesting that a large amount of PIT1 antagonizes the E 2 -ERa-dependent inhibition of the TSHb gene. We recently found that deletion of a short sequence between GATA-REs and the TATA-box in the TSHb promoter (nt. 82/52; Fig. 1A ) enabled GATA2 alone to transactivate without PIT1 (Matsushita et al. 2007 ), and we designated this deleted sequence as the suppressor region (SR). The construct TSHb-M1-CAT ( Fig. 2B , left panel) in which SR was deleted was activated by GATA2 alone, and this activity was inhibited by E 2 -ERa ( Fig. 2B, right panel) . GATA2 alone without PIT1 transactivated two other reporter constructs, TSHb-D4-CAT, in which nTRE/NRE in TSHb-M1-CAT was mutated (Matsushita et al. 2007) , and CGA-CAT, which possesses a functional GATA-RE (Steger et al. 1994) . Again, E 2 -ERa repressed the GATA2-induced transactivation of TSHb-D4-CAT and CGA-CAT by 53 . 1%G1 . 9 S.E.M. and 30 . 5%G6 . 2 S.E.M. respectively (data not shown). Collectively, transactivation by GATA2 alone was sufficient to mediate negative regulation by E 2 -ERa and PIT1 antagonized this inhibition.
The Zn finger domain of GATA2 directly interacts with TR and ERa in vitro
The amino acid sequence of the Zn finger domain of GATA2 (GATA2-Zf), but not the N-or C-terminal region, has high homology with that of GATA1 (Fig. 3A) , and both GATAs are known to transactivate the same GATA-RE. In addition, E 2 -ERa was reported to inhibit GATA1-induced transactivation (Blobel et al. 1995) . As predicted, GATA1induced transactivation of TSHb-CAT was also repressed by E 2 -ERa (Fig. 3B ). While C-terminal finger of GATA1 directly recognizes the GATA-RE, the N-terminal finger is known to interact with Friend of GATA (FOG) 1 and 2 that are the strong co-repressor for the GATA family transcription factors. We reported (Matsushita et al. 2007 ) that transactivation by a mutant GATA2, GATA2-C295A (Fig. 3A) , which has an amino acid substitution from cysteine to alanine at codon 295 of the N-terminal Zn finger, was resistant to the inhibition by T 3 -TRb2. The finding that the basal transcription by C295A was significantly higher than that by empty vector (Fig. 3C) indicates that the overall structure as functional GATA2 is partly preserved in this mutant. However, transactivation induced by GATA2-C295A was not inhibited by E 2 -ERa. These findings indicate that interaction between GATA2-Zf and ERa is essential to E 2 -ERa-mediated inhibition. Using the GST fusion protein with GATA2-Zf (GST-Zf, Fig. 3A) , we tested the direct interaction between ERa and GATA2-Zf in vitro. As reported previously (Matsushita et al. 2007 ), GST-Zf interacted with TRb1 ( Fig. 3D, upper panel) but not the luciferase protein (lower panel). In an E 2independent manner, GST-Zf also bound to radio-labeled full-length ERa (Fig. 3D, middle panel) . As shown in Fig. 3E , the mutant ERas N2 and D247, which lacked DBD, did not interact with GST-Zf, suggesting that ERa-DBD binds to GATA2-Zf as in the case of THRB-DBD. The E 2 -ERa-induced inhibition of the TSHb promoter does not require the second Zn finger motif P-and D-boxes and the zinc finger structure in DBD are critical constituents that determine receptor specificity in liganddependent positive regulation (Mangelsdorf et al. 1995) . To investigate the involvement of these motifs in the negative regulation of the TSHb gene, we generated three mutant ERas: C205S in the P-box and C221G and C240S in the stem of the second Zn finger (Fig. 4A, upper panel) . Western blot analysis with an anti-ERa antibody indicated that expression levels of these mutants in CV1 cells were comparable (lower panel). As predicted, these mutants lost DNA-binding affinity as demonstrated by gel shift assay with vitellogenin A2-derived ERE (vit-A2-ERE; Scott et al. 1997 ; Fig. 4B ), and failed to activate the ERE-tk-CAT reporter gene, in which vit-A2 ERE is fused to the CAT reporter gene driven by the thymidine kinase (tk) promoter ( Fig. 4C, left panel) . As shown in the right panel of Fig. 4C , negative regulation of the TSHb promoter induced by PIT1 and GATA2 was abolished in C205S and C221G. The findings that C205S and C221G directly interacted with GATA2-Zf (Fig. 4D ) suggest that physical interaction of ERa-DBD with GATA2 is not sufficient for inhibition by E 2 -ERa. Unexpectedly, another mutant ERa, C240S (Fig. 4A ) preserved E 2 -induced negative regulation of the TSHb gene ( Fig. 4C ) as well as in vitro binding with GATA2-Zf ( Fig. 4D ), suggesting that the tertiary structure of the second Zn finger motif, which is necessary for ERE recognition, is dispensable for inhibition of the TSHb gene.
The E 2 -induced inhibition of the TSHb promoter requires ERa-NTD
We previously reported that TRb1-NTD is dispensable for the negative regulation of the TSHb promoter (Nakano et al. 2004) . We wanted to compare the function of NTDs of ERa. In contrast to TRb1, the ERa-NTD truncation mutant D170 (Fig. 5A , middle upper panel) did not inhibit but rather stimulated the transcription (right panel), although it mediated positive regulation (left panel). These data suggest that ERa-NTD is critical for inhibition by E 2 . As predicted, ERa (D247), which lacks the DBD, did not exhibit liganddependent transactivation or inhibition. The expression levels of mutant ERas were comparable (middle lower panel).
As shown in Fig. 5B , the amino acid sequences between ERa and ERb were conserved in their DBD (96%) and LBD (58%) but not in NTDs (McInerney et al. 1998) . We found that repression of the TSHb promoter by E 2 -ERb was impaired and the effect of E 2 was not statistically significant ( Fig. 5C ). To exclude the possibility that ERa-LBD may communicate with the NTD of the same ERa molecule, we tested the function of the chimeric ERa, bNaC, in which the NTD was substituted with that of ERa (Yi et al. 2002 ; Fig. 5B ). Again, bNaC failed to mediate E 2 -dependent repression (Fig. 5D ). Western blotting with an antibody against the C-terminal region of ERa indicated that expression levels of wild-type ERa and bNaC were comparable (Fig. 5E ). Together, these findings indicate that the ERa-NTD has an important role in E 2 -dependent inhibition.
Effect of E 2 on the expression of the TSHb gene in thyrotroph cell line TaT1
Serum E 2 concentration is known to influence not only the level of T 4 -binding globulin (TBG; Surks & Sievert 1995) but also the production of T 3 and T 4 from the thyroid gland (Furlanetto et al. 1999 , Sosic-Jurjevic et al. 2005 , Alotaibi et al. 2006 , Lima et al. 2006 . Using cultured thyrotroph cell line TaT1 (Yusta et al. 1998) , we studied the direct effect of E 2 on the TSHb mRNA level. When TSHb mRNA was detected by conventional RT-PCR, not only T 3 but also E 2 reduced the intensity of the TSHb mRNA band (Fig. 6A) . We further measured TSHb mRNA expression by real-time quantative RT-PCR (Fig. 6B ). Although the magnitude was smaller than that for T 3 , E 2 treatment also significantly reduced the level of TSHb mRNA (67 . 2%G12 . 1 S.E.M. vs 49 . 5%G14 . 9 S.E.M., P!0 . 05). The magnitudes of suppression were correlated to those from the reporter assay using TSHb-CAT (Fig. 1B) .
Comparison of serum TSH levels between pre-and postmenopausal women
To evaluate the clinical significance of E 2 effects on serum TSH, we compared the serum TSH level of 72 postmenopausal women with that of 62 premenopausal women, (Mariotti et al. 1993) , we recruited female subjects with ages up to 70 years old as the postmenopausal population. As predicted, the serum E 2 levels in postmenopausal females were very low (Fig. 7, left panel) . Although there was no difference in the free T 4 concentrations (middle panel), the serum TSH level of the postmenopausal group was significantly higher than that of the premenopausal group (right panel).
Discussion
In the present study, we demonstrated that E 2 -ERa inhibits transactivation of the TSHb gene through a mechanism similar to inhibition by T 3 -TRs. We used reporter assay in the CV1 cell line, which is ideal for comparing the mechanism of ligand-dependent negative regulation of the TSHb gene with that of positive regulation (Nakano et al. 2004) . Our findings imply that redundancy in the recognition of target genes exists not only in the positive regulation (Klinge et al. 1997 , Scott et al. 1997 but also in the negative regulation of the TSHb gene. It was postulated that E 2 -dependent inhibition of the Figure 3 The interaction between GATA2-Zf and ERa-DBD. (A) Schematic of GATA1, GATA2, GATA2-C295A, and GST-Zf. The boundaries of the Zn finger region were deduced by comparison with chicken GATA1 reported by Boyes et al. (1998) . The homology of amino acids among GATA1 relative to GATA2 is indicated as a percentage in the boxes. In GST-Zf, GST protein was fused to GATA2-Zf. (B) The transactivation of TSHb-CAT by GATA1 and GATA2 was suppressed by E 2 -ERa. The expression plasmids for mouse GATA1 or 2 (0 . 4 mg) were transfected together with that for PIT1 (0 . 1 mg) into CV1 cells. The results are shown as the meansGS.E.M. from six independent experiments. (C) The expression plasmids for mouse GATA2 or GATA2-C295A (0 . 4 mg)
were transfected into CV1 cells under the same conditions as Fig. 1B . The results are shown as the meansGS.E.M. from six independent experiments. The magnitude of the CAT activity stimulated by wild-type GATA2 and PIT1 was taken as 100%. TSHb gene was mediated via direct binding of ERa with the putative nTRE (Wondisford 1996) . However, this is unlikely, because E 2 -induced inhibition is preserved in the ERa mutant C240S, which fails to bind or activate canonical vit-A2-ERE (Fig. 4C ). In agreement with this, E 2 -ERa inhibited GATA2-induced transactivation of TSHb-D4-CAT, which lacked a DNA sequence homologous to the half-site. Moreover, E 2 -ERa repressed the activity of TSHb-M1-CAT ( Fig. 2B) and CGA-CAT stimulated by GATA2 alone (data not shown), suggesting that interference of GATA2-induced transactivation by E 2 -ERa is the mechanism for inhibition of the TSHb gene. This notion is further supported by the observation that transactivation by the mutant GATA2-C295A was resistant to E 2 -ERa-induced suppression (Fig. 3C) . ERa interacts directly with PIT1 (Ying et al. 1999) , and these two transcription factors synergize in the transactivation of the prolactin gene in lactotrophs (Chuang et al. 1997 , Schaufele 1999 , whose most important PIT1-binding site is located adjacent to the ERE (Nowakowski & Maurer 1994 ). However, current results indicate that E 2 -ERa-dependent inhibition of the TSHb promoter does not require PIT1 (Fig. 2B) and is rather crippled by the overexpression of this transcription factor ( Fig. 2A) .
Although the results of the transfection experiments as well as the cell culture studies are obtained with high pharmacological doses of E 2 , the overall results were in accordance with our recent findings regarding the T 3 -dependent inhibition of the TSHb gene (Matsushita et al. 2007 ). The repression of GATA2-induced activation by E 2 -ERa and T 3 -TR may occur by a 'tethering mechanism' (Nissen & Yamamoto 2000 , Herrlich 2001 , where liganded nuclear receptors interfere with the activity of DNA-binding transcription factors through protein-protein interactions. In this kind of inhibition, redundancy among liganded and 240 in the stem of second Zn finger were substituted to serine (C205S), glycine (C221G), and serine (C240S). The expression levels of wild-type and mutant ERas were comparable (lower panel). CV1 cells were transfected with the expression plasmids for wild-type or mutant ERas. Whole cell extracts were fractionated by SDS-PAGE and subjected to western blot (WB) with anti-ERa antibody against the C-terminal region of ERa. (B) 32 P-radio-labeled vit-A2 ERE was incubated with in vitro-translated protein for wild-type or mutant ERas. ERE, specific cold competitor. NS, non-specific cold oligo DNA. Arrow, specific binding of ERa; arrowhead, nonspecific binding. (C) ERE-tk-CAT (left panel) was transfected into CV1 cells together with the expression plasmid for ERa in the presence or absence of 1 mM E 2 . CAT activity with 1 mM E 2 was divided by that without E 2 to calculate fold activation. TSHb-CAT (right panel) was transfected into CV1 cells together with the expression plasmids for PIT1, GATA2, and wild or mutant ERas as shown in Fig. 1B . CAT activity without E 2 was divided by that with 1 mM E 2 to calculate fold repression. (D) 35 S-radio-labeled receptors were incubated with GST protein fused to GST-Zf and binding fractions were subjected to SDS-PAGE.
receptors has been reported. For example, E 2 -ERa (Kalaitzidis & Gilmore 2005) and glucocorticoid (GC)bound GC receptor (GR; McKay & Cidlowski 1999 , De Bosscher et al. 2003 repress transactivation by the proinflammatory transcription factor NF-kB by interacting with it. Similarly, the transcriptional activity of AP-1 (typically the Jun/Fos heterodimer) is impaired by T 3 -TR and GC-GR (De Bosscher et al. 2003) .
Although the precise mechanism of how E 2 -ERa inhibits the function of GATA2 in transactivation of the TSHb gene is uncertain, the present analysis provides several insights. First, the GST pull-down assay (Fig. 3E ) indicated that DBD is essential for the interaction of ERa with GATA2-Zf as in the case of THRBs (Matsushita et al. 2007) . Second, E 2dependent inhibition does not require the tertiary structure of the second Zn finger motif in ERa-DBD, since E 2dependent inhibition was preserved in the mutant ERa C240S (Fig. 4C) , which contains a disrupted second Zn finger motif (Fig. 4A ). Third, it should be noted that the mutant ERas, C205S, and C221G, failed to inhibit E 2dependent inhibition of the TSHb gene (Fig. 4C) , although both mutants can physically bind GATA2-Zf in vitro receptor expression plasmids. The CAT activity with the ligand was divided by that without ligand to calculate fold activation (left panels). The CAT activity without ligand was divided by that with 1 mM ligand to calculate fold repression (right panels). The expression levels of wild-type and mutant ERas were comparable (middle lower panel). The CV1 cells were transfected with the expression plasmid for wild-type or mutant ERaD170 and D247). Western blot (WB) was performed as Fig. 4A. (B) Schematic of ERa, ERb and chimeric receptor bNaC. In bNaC, NTD of ERa is replaced with that of ERb. The homology of amino acids among ERb and bNaC relative to ERa is indicated as a percentage in the boxes. (C) The expression plasmid for ERa or ERb was transfected into CV1 cells together with TSHb-CAT and the expression plasmids for PIT1 and GATA2. # P!0 . 05 versus PIT1 and GATA2. (D) In the presence or absence of 1 mM E 2 , the expression plasmid for ERa or bNaC was transfected into CV1 cells together with TSHb-CAT and the expression plasmids for PIT1 and GATA2. CAT activity without E 2 was divided by that with E 2 (1 mM) to calculate the fold repression (right panel). The results are shown as meansGS.E.M. for eight separate experiments. *P!0 . 05. (E) Expression levels of wild-type ERa and bNaC were comparable. The CV1 cells were transfected with the expression plasmid for wild-type or bNaC and western blot with antibody against the C-terminal region of ERa was performed as Fig. 4A . (Fig. 4D) . The same results were obtained with the mutant TRb2 G182E (Matsushita et al. 2007 ) and the mutant TRb1 C127S and C145G (Nakano et al. 2004 and data not shown). Physical binding alone is not sufficient to mediate liganddependent inhibition, and subtle changes of amino acids on the surface of DBD may be functionally critical. Similar conclusions were made after analysis of mutant GR using circular dichroism (Tao et al. 2001 ).
GATA2-Zf interacts with multiple coactivators including CBP/p300 (Blobel et al. 1998 , Hayakawa et al. 2004 , TRAP220 (Crawford et al. 2002 , and transcriptional repressors such as HDAC3 (Ozawa et al. 2001) and FOG 1 and 2 (Ferreira et al. 2005) . ERa and TR share common coactivators including the p160 family (SRC1, TIF2/GRIP1, and AIB1/ACTR), CBP/p300, p300/CBPassociating factor (PCAF), and TRAP220. As in the case of T 3 -THRBs (Matsushita et al. 2007 ), overexpression of SRC-1, CBP, or PCAF did not show reproducible effects on the negative regulation of the TSHb gene by E 2 -ERa (data not shown). TRAP220 is required for the expression of the TSHb gene (Ito et al. 2000) and functions as a coactivator for GATA2 , GATA1 (Stumpf et al. 2006 ), TR (Ito & Roeder 2001) , and ERa (Zhang et al. 2005) . TR (Ito & Roeder 2001) and ERa (Zhang et al. 2005) recognize an extended amino acid sequence encompassing two LXXLL motifs in TRAP220 with a specificity distinct from that of coactivators in the p160 family (Acevedo & Kraus 2003 , Coulthard et al. 2003 . We reported that dnTRAP220 (Yuan et al. 1998 ) relieved the T 3 -TR-dependent inhibition of the TSHb promoter and that TRAP220 dissociated from this promoter after T 3 treatment of TaT1 cells (Matsushita et al. 2007) . We found that the expression of the dnTRAP220 also abolished the E 2 -ERa-induced inhibition of the TSHb gene (data not shown). Thus, TRAP220 may play a role in the inhibition of the TSHb gene by E 2 -ERa and T 3 -TR.
We found that ERa-NTD plays an essential role in the repression of the TSHb gene by E 2 (Fig. 5 ). This domain interacts directly with the p160 family (Lavinsky et al. 1998 , Webb et al. 1998 ), p300 (Kobayashi et al. 2000) , HDAC4 (Leong et al. 2005) , and repressor of tamoxifen transcriptional activity (Norris et al. 2002) . Although ERa-NTD may bind directly with LBD (Kraus et al. 1995 , Metivier et al. 2000 or regulate the interaction between the antagonist bound LBD and its co-repressor (Lavinsky et al. 1998) , the bNaC data indicate that ERa-NTD has an intrinsic function to control the E 2 -dependent inhibition of the TSHb gene. TRb2-NTD was reported to have a strong T 3 -independent transactivation effect on TRE (Sjoberg & Vennstrom 1995) and also to regulate the interaction between LBD and SMRT (Yang & Privalsky 2001) . A function unique to TRb2-NTD may account for its stronger repression of the TSHb gene than TRb1 (Nakano et al. 2004 ). Importance of GR-NTD was also reported for ligand-dependent inhibition of AP-1 activity (Heck et al. 1994 ). E 2 is known to have profound influence on the thyroid hormone system, including cell proliferation (Furlanetto et al. 1999) , iodine uptake (Furlanetto et al. 1999 , Alotaibi et al. 2006 , Lima et al. 2006 , thyroid peroxidase activity (Lima et al. 2006) , de-iodinases (Lisboa et al. 2001 , Wasco et al. 2003 ), or TBG (Gross et al. 1971 , Surks & Sievert 1995 , Arafah 2001 . Altered thyroid hormone production and metabolism may mask the direct effect of E 2 on TSHb expression. To exclude the influences of E 2 on T 3 and T 4 levels in the circulating blood, we measured TSHb mRNA in TaT1 cells and found that E 2 significantly repressed the expression of TSHb mRNA (Fig. 6 ). We studied serum TSH levels in women with simple goiter or thyroid nodule(s), who had no thyroid autoantibodies. The TSH level was significantly higher in the postmenopausal than premenopausal population (Fig. 7) . Since the age of the postmenopause group was between 50 and 70 years old, thyroidal deterioration due to aging is unlikely (Mariotti et al. 1993) . A small but significant increase in the TSH level after menopause may be related to the decreased TSH suppression by E 2 . Although free T 4 or serum E 2 data were not available, the NHANES III report (Hollowell et al. 2002) also showed that the TSH concentration tended to increase with age in female populations without thyroid autoantibodies. Surks & Hollowell (2007) have recently analyzed TSH frequency distribution curves in NHANES III and showed the progressive shift toward higher concentrations of TSH with age irrespective of thyroid antibodies. They say that an explanation for this shift to higher TSH ranges in elderly people is not apparent, but we consider that our finding in this study is one of the main factors.
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